1 Cancer Research UK London Research Institute, London; UCL Cancer Institute and Hospitals, London, UK. Electronic address: charles.swanton@cancer.org.uk.
This editorial will review our current understanding of intratumour heterogeneity and cancer evolution and its potential impact on patient outcome and biomarker validation.